Form 4: Compugen Executive Receives Stock Grant
Insider Transaction (Form 4)
Michelle Mahler, Chief Medical Officer of Compugen Ltd, reported multiple transactions in common stock on July 29, 2026.
Summary
- Grant/award: acquired 13,500 Ordinary Shares on July 29, 2026; holds 36,625 after (Direct).
- Grant/award: acquired 18,000 Share Option (right to buy) on July 29, 2026; holds 18,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Michelle Mahler — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-29 | Grant/award | Ordinary Shares | 13,500 | — | — | 36,625 |
| 2026-07-29 | Grant/award | Share Option (right to buy) | 18,000 | — | — | 18,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-29 | Grant/award (13,500 shares) |
| 2026-07-29 | Grant/award (18,000 shares) |
Keywords
insider transaction, Form 4, CGEN, COMPUGEN LTD, neutral, Michelle Mahler
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.